Email Updates

Search form

You are here

Webinar & Meeting Reports

  • June 13, 2017

    In this webinar, Jeff Taylor from the Care Collaboratory CAB at the University of North Carolina will discuss the basics needed to understand cure research and clinical trials, utilizing the CUREiculum, AVAC's cure education tool.

  • June 13, 2017 to June 15, 2017

    From the conference website:
    Southern Africa is in its strongest position yet when it comes to control of the AIDS epidemic, however there are a number of major gaps that still need to be addressed and plugged. Prevention has always been the poor relative of the epidemic (one cannot ignore people already infected), and social and structural change had been the orphan of prevention. In the 8th Southern African Conference you can find the latest advances in basic sciences alongside an emphasis on how to be part of lasting change to prevent new infections.

  • May 23, 2017 to May 25, 2017

    For more information, including the At-A-Glance and full program, click here.

  • May 18, 2017

    Lieutenant Colonel Julie Ake, Principal Deputy Director of the US Military HIV Research Program (MHRP), wraps up our HVAD webinar series by providing an overview of MHRP’s HIV program and helping to connect dots in the HIV vaccine field.

  • May 18, 2017

    This year marks the 20th anniversary of HIV Vaccine Awareness Day (HVAD). We highlight these important issues in an HVAD webinar series leading up to and ending on May 18.

  • May 11, 2017

    Dr. Lynn Morris provided an overview of antibody research for HIV prevention. She laid out the current landscape; provided a glimpse of what is to come in this dynamic field; talked about where antibody work fits in the larger field of prevention research; and described how the Antibody Mediated Prevention (AMP) studies – ongoing proof-of-concept trials of the broadly neutralizing antibody VRC01 – might advance HIV prevention.

  • May 8, 2017

    Dr. Fatima Laher, protocol co-chair of HVTN 702, provides an overview of the first HIV vaccine efficacy trial in seven years. Her presentation looks at the history, starting with partial success of RV144 in 2009, and talks about the role HVTN 702 as the field advances toward an effective vaccine.

  • May 4, 2017

    Long-time vaccine researcher Barney Graham presented an excellent overview of the history and work of NIH’s Vaccine Research Center (VRC)—established two decades ago on the inaugural HIV Vaccine Awareness Day (HVAD) in 1997. Download the recording for an accessible overview of the HIV vaccine field, the connections between the work on HIV and other vaccines at the VRC and tips on what advocates and researchers should be calling for this HVAD.

  • April 28, 2017

    The HIV Vaccine Awareness Day 2017 webinar series kicked off with an overview of the Ad26/mosaic vaccine efficacy program from Janssen’s Maria Grazia Pau. This strategy is notable both for the science and for the active leadership from industry. Dr. Pau did a terrific job of explaining where the strategy fits into the broader vaccine field.

  • April 26, 2017

    In this webinar, we were joined by Dr. James Kiarie, coordinator of the Human Reproduction Team at the World Health Organization. Dr. Kiarie presented new guidance from WHO on hormonal contraceptive eligibility for women at high risk of HIV. He also fielded questions from webinar participants.

Pages